CoRoent
Device
NUVASIVE, INC.
Total Payments
$6.6M
Transactions
940
Doctors
286
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $549,577 | 119 | 27 |
| 2023 | $838,729 | 47 | 24 |
| 2022 | $588,710 | 62 | 28 |
| 2021 | $435,103 | 87 | 49 |
| 2020 | $779,921 | 92 | 49 |
| 2019 | $752,977 | 133 | 84 |
| 2018 | $1.5M | 193 | 110 |
| 2017 | $1.1M | 207 | 104 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $6.4M | 480 | 98.2% |
| Unspecified | $95,710 | 29 | 1.5% |
| Food and Beverage | $17,140 | 416 | 0.3% |
| Consulting Fee | $1,500 | 1 | 0.0% |
| Travel and Lodging | $620.84 | 13 | 0.0% |
| Education | $34.91 | 1 | 0.0% |
Payments by Type
General
$6.5M
911 transactions
Research
$95,710
29 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the thoracic and/or lumbar spine | NuVasive, Inc. | $25,409 | 0 |
| NUVA.LIB1119: A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the thoracic and/or lumbar spine | NuVasive, Inc. | $19,980 | 0 |
| A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the thoracic and/or lumbar spine | Globus Medical, Inc. | $11,887 | 0 |
| A Retrospective Review of the Clinical and Radiographic Outcomes Following the Use of the NuVasive Cervical Interbody Implants with Attrax Putty for Degenerative Cervical Pathologies | Globus Medical, Inc. | $9,749 | 0 |
| Retrospective chart review of the safety and performance of Coroent Small Interlock 2 for the treatment of patients with cervical disc disease: A single center experience | NuVasive, Inc. | $8,000 | 0 |
| NUVA.CIB0420: A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the cervical spine | NuVasive, Inc. | $6,533 | 0 |
| NUVA.CERV1601 A Retrospective Review of Surgical Treatments and Outcomes for Degenerative Cervical Pathologies | NuVasive, Inc. | $5,210 | 1 |
| NUVA.CERV1701 A Retrospective Review of the Clinical and Radiographic Outcomes Following the Use of the CoRoent Small Interlock System Interbody Spacer in Multilevel Degenerative Cervical Pathologies | NuVasive, Inc. | $4,030 | 1 |
| A Prospective, Multicenter Study Evaluating the Safety and Performance of Interbody Implants for the Treatment of Patients With Degenerative Conditions of the thoracic and/or lumbar spine | NuVasive, Inc. | $3,723 | 0 |
| NUVA.CACR1601 A Retrospective Review of Cervical Anterior Column Realignment (ACR) Procedures and Outcomes for Cervical Pathologies | NuVasive, Inc. | $750.00 | 1 |
| NUVA.CERV1701 A Retrospective Review of the Clinical and Radiographic Outcomes Following the Use of the CoRoent?? Small Interlock System Interbody Spacer in Multilevel Degenerative Cervical Pathologies | NuVasive, Inc. | $440.00 | 0 |
Top Doctors Receiving Payments for CoRoent
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Neurological Surgery | San Diego, CA | $750,783 | 11 |
| , MD | Orthopaedic Surgery | Charlotte, NC | $750,574 | 28 |
| , MD | Neurological Surgery | Charlottesville, VA | $618,807 | 12 |
| , MD | Orthopaedic Surgery of the Spine | Raleigh, NC | $340,889 | 15 |
| , MD | Orthopaedic Surgery | Munster, IN | $300,884 | 15 |
| , M.D | Orthopaedic Surgery | Oklahoma City, OK | $292,845 | 22 |
| , M.D | Orthopaedic Surgery of the Spine | Spokane, WA | $288,635 | 8 |
| , M.D | Neurological Surgery | Boston, MA | $279,061 | 29 |
| , M.D | Specialist | San Diego, CA | $262,549 | 5 |
| , MD | Orthopaedic Surgery | Fishers, IN | $213,540 | 15 |
| , M.D | Orthopaedic Surgery of the Spine | Durango, CO | $212,798 | 17 |
| , MD | Orthopaedic Surgery | San Francisco, CA | $212,193 | 18 |
| , M.D | Orthopaedic Surgery | La Jolla, CA | $206,793 | 13 |
| , MD | Orthopaedic Surgery | Albuquerque, NM | $206,500 | 9 |
| , M.D | Orthopaedic Surgery of the Spine | Roseville, CA | $157,537 | 42 |
| , M.D | Neurological Surgery | San Diego, CA | $147,202 | 14 |
| , MD | Neurological Surgery | Tampa, FL | $144,109 | 34 |
| , MD | Orthopaedic Surgery of the Spine | Savannah, GA | $115,609 | 13 |
| , MD | Pain Medicine | Albuquerque, NM | $108,274 | 20 |
| , MD | Neurological Surgery | Tulsa, OK | $102,218 | 29 |
| Unknown | — | Los Angeles, CA | $87,800 | 26 |
| , MD | Orthopaedic Surgery of the Spine | Medford, OR | $87,738 | 14 |
| , M.D | Orthopaedic Surgery | Hamilton, NY | $83,343 | 23 |
| , MD | Orthopaedic Surgery of the Spine | Boston, MA | $66,825 | 1 |
| , MD | Neurological Surgery | Pomona, CA | $61,046 | 29 |
Ad
Manufacturing Companies
- NuVasive, Inc. $4.9M
- NUVASIVE, INC. $1.1M
- Globus Medical, Inc. $549,577
Product Information
- Type Device
- Total Payments $6.6M
- Total Doctors 286
- Transactions 940
About CoRoent
CoRoent is a device associated with $6.6M in payments to 286 healthcare providers, recorded across 940 transactions in the CMS Open Payments database. The primary manufacturer is NUVASIVE, INC..
Payment data is available from 2017 to 2024. In 2024, $549,577 was paid across 119 transactions to 27 doctors.
The most common payment nature for CoRoent is "Royalty or License" ($6.4M, 98.2% of total).
CoRoent is associated with 11 research studies, including "A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the thoracic and/or lumbar spine" ($25,409).